Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Nrf2 activation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| mitochondrial biogenesis | activates | process | 0.90 |
| neurodegenerative diseases | protective_against | disease | 0.90 |
| cardiovascular mortality | risk_factor_for | phenotype | 0.90 |
| ALS | associated_with | disease | 0.70 |
| AD pathology | protective_against | disease | 0.70 |
| therapeutic window | modulates | process | 0.70 |
| motor neuron death | protective_against | phenotype | 0.70 |
| GPX4 | upregulates | protein | 0.70 |
| SLC7A11 | upregulates | protein | 0.70 |
| ferroptosis | inhibits | mechanism | 0.70 |
| motor neuron survival | protects | phenotype | 0.70 |
| brain ischemia/reperfusion injury | protects_against | process | 0.70 |
| Neurodegeneration | protective_against | disease | 0.70 |
| redox homeostasis impairment | prevents | mechanism | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Elevated KEAP1 | inhibits | protein | 0.90 |
| Dimethyl fumarate | activates | drug | 0.90 |
| p62 impairment | inhibits | mechanism | 0.70 |
| p62-mediated autophagy impairment | inhibits | process | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| NRF2 Activation Provides Neuroprotection Across ALS, AD, and | 0.710 | neurodegeneration | Test Preregistration Analysis |
| Endothelial NRF2 Activation as a Master Switch for Post-CA B | 0.689 | neurodegeneration | View |
| HBOT at 1.5 ATA for 60 min induces hormetic response via Nrf | 0.640 | neurodegeneration | What are the optimal oxygen pressure, du |
| oxLDL/LOX-1/ROS Signaling Induces P2RY12 via Nrf2 Activation | 0.550 | neurodegeneration | What determines P2RY12 receptor expressi |
| NRF2 Activation to Counteract Oxidative Stress from RGS6 Def | 0.518 | neurodegeneration | Does RGS6 upregulation or D2 autorecepto |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-27 | 7 hypotheses Top: 0.710
neurodegeneration | 2026-04-16 | 7 hypotheses Top: 0.680
neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.661
neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.604
neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.521
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
active · Rounds: 4 · Score: 0.77 · 2026-04-28
closed · Rounds: 4 · Score: 0.70 · 2026-04-21
closed · Rounds: 4 · Score: 0.50 · 2026-04-20
closed · Rounds: 5 · Score: 0.59 · 2026-04-16
closed · Rounds: 4 · Score: 0.70 · 2026-04-16
closed · Rounds: 4 · Score: 0.95 · 2026-04-16
closed · Rounds: 4 · Score: 0.95 · 2026-04-16
Hypotheses and analyses mentioning Nrf2 activation in their description or question text
No additional research found